Can a diabetes drug transform the treatment of obesity?

In people with obesity, a high-dose weekly injection of the diabetes drug semaglutide caused a 15% weight loss and improved other heart-related risk factors. Semaglutide works by mimicking a substance called GLP-1, which is made naturally by the gut and the brain. It prods the pancreas to release insulin when blood sugar rises too high, reduces appetite, and makes people feel full following a meal.

Content restricted. Requires subscription

Are you wasting money on supplements?

Taking multivitamins doesn’t prevent heart attacks or strokes, and most dietary supplements (such as fish oil, red yeast rice, and coenzyme Q10) offer no or limited benefits for avoiding heart-related problems. For people who don’t have heart disease, eating two servings of fatty fish weekly or following a healthy vegetarian diet rich in nuts, legumes, and healthy oils makes more sense than spending money on over-the-counter fish oil supplements. People with heart disease would be better off asking their doctor about the prescription drug icosapent ethyl (Vascepa), a high-dose, purified EPA that lowers cardiovascular risk when taken with a statin.

Content restricted. Requires subscription

COVID-19 vaccines: Safe and effective for American Indian and Alaskan Native communities

Concerns circulating about the effectiveness of the Johnson & Johnson vaccine in American Indian/Alaskan Native communities, compared to the other available vaccines for COVID-19, have been answered by responses from medical professionals within the Indigenous population, as well as by statistics showing that all three vaccines are safe and effective in people of all races and ethnic backgrounds.

Content restricted. Requires subscription

American Heart Association issues statement on cardiovascular side effects from hormonal therapy for prostate cancer

The American Heart Association issued a statement addressing cardiovascular risks from hormonal therapy for prostate cancer, emphasizing the need to identify men with pre-existing cardiac risk factors or a family history of cardiovascular diseases who should be monitored closely during treatment.

Content restricted. Requires subscription